Aperio Group’s Radius Health, Inc. RDUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-10,715
Closed -$122K 2451
2020
Q3
$122K Sell
10,715
-1,300
-11% -$16.1K ﹤0.01% 2300
2020
Q2
$164K Buy
+12,015
New +$165K ﹤0.01% 2212
2019
Q4
Sell
-9,958
Closed -$256K 2353
2019
Q3
$256K Buy
9,958
+617
+7% +$15.1K ﹤0.01% 2084
2019
Q2
$228K Sell
9,341
-1,083
-10% -$23.7K ﹤0.01% 2132
2019
Q1
$208K Sell
10,424
-5,349
-34% -$97.6K ﹤0.01% 2143
2018
Q4
$260K Buy
+15,773
New +$266K ﹤0.01% 2014
2018
Q2
Sell
-6,420
Closed -$231K 2293
2018
Q1
$231K Buy
+6,420
New +$232K ﹤0.01% 2074
2017
Q2
Sell
-5,624
Closed -$217K 2228
2017
Q1
$217K Buy
+5,624
New +$236K ﹤0.01% 2002

Other funds holding RDUS

Aperio Group's RDUS Position: Q4 2020 in Review

Aperio Group sold out of Radius Health, Inc. (RDUS) in Q4 2020, closing a stake of 10,715 shares — an estimated $122K sold.

Aperio Group first reported a position in RDUS in Q1 2017 and held it in 8 quarters. The position peaked at $260K in Q4 2018. 132 funds tracked by Wall St. Rank hold RDUS as of Q4 2020.

  • Aperio Group reported no remaining Radius Health, Inc. position as of Q4 2020 after selling out during the quarter.
  • Aperio Group sold 10,715 Radius Health, Inc. shares in Q4 2020, an estimated $122K.
  • Aperio Group first reported a position in Radius Health, Inc. in Q1 2017 and held it in 8 quarters.
  • Aperio Group's Radius Health, Inc. position peaked at $260K in Q4 2018.
  • 132 funds tracked by Wall St. Rank held Radius Health, Inc. as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.